AGE-GROUP SPECIFIC COVERAGE OF THE HUNGARIAN ORGANIZED NATIONWIDE CERVICAL CANCER SCREENING PROGRAMME
Author(s)
József Betlehem, BSc, MSc, deputy director general1, Imre Boncz, MD, MSc, department head2, Andor Sebestyén, MD, MBA, deputy director2, Lajos Döbrõssy, MD, PhD, senior advisor3, András Budai, MD, national coordinator3, István Ember, MD, PhD, DSc, department head11University of Pécs, Pécs, Hungary; 2 National Health Insurance Fund Administration (OEP), Budapest, Hungary; 3 National Public Health and Medical Officers Service (ÁNTSZ), Budapest, Hungary
OBJECTIVES: Organized nationwide screening programme for cervical cancer was introduced in Hungary in 2003. Women between the ages 25-65 are invited by a personal letter and a 3 years screening interval has been applied. The aim of this study is to analyse the three year screening rate (attendance or coverage) of the organized programme according to the age-group of target population. METHODS: The data derive from the financial database of the National Health Insurance Fund Administration (OEP) of Hungary covering the period of 2000-2002 and 2003-2005. We calculated the three-year screening rate for 2003-2005 according to the age-group of women. Screening is defined with cytological examination of Papanicolau smear and includes all smears taken either within or outside of the organized programme. RESULTS: The three-year screening rate of women aged 25-64 years increased from 48, 45 % in 2000-2002 without organized screening programme to 52, 65 % in 2003-2005 following the introduction of organized screening programme. The three-year screening was the following in 2003-2005 according the age-groups: 25-29 years: 64, 24 %; 30-34 years: 66%; 35-39 years: 60, 89 %; 40-44 years: 55, 34 %; 45-49 years: 50, 44 %; 50-54 years: 49, 23%; 55-59 years: 39, 74%; 60-64 years: 31, 80%. CONCLUSIONS: After the introduction of organized cervical screening programme we found the highest screening rate in the age-group 30-34 years followed by a gradually decreasing screening rates in the higher age-groups. In order to achieve the expected mortality decline from cervical cancer, the screening rate (attendance) of women 40-64 should be increased.
Conference/Value in Health Info
2006-10, ISPOR Europe 2006, Copenhagen, Denmark
Value in Health, Vol. 9, No.6 (November/December 2006)
Code
PCN53
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Health Care Research
Disease
Oncology